Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for AVIR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 28.12M
March 31, 2026 33.37M
December 31, 2025 39.78M
September 30, 2025 27.18M
June 30, 2025 27.19M
March 31, 2025 28.88M
December 31, 2024 25.80M
September 30, 2024 32.44M
June 30, 2024 33.91M
March 31, 2024 48.66M
December 31, 2023 39.78M
September 30, 2023 26.34M
June 30, 2023 23.68M
March 31, 2023 19.95M
Date Value
December 31, 2022 26.14M
September 30, 2022 23.39M
June 30, 2022 33.88M
March 31, 2022 37.30M
December 31, 2021 62.82M
September 30, 2021 262.05M
June 30, 2021 273.68M
March 31, 2021 254.39M
December 31, 2020 315.83M
September 30, 2020 10.87M
June 30, 2020 7.127M
March 31, 2020 2.009M
December 31, 2019 2.53M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Filana Therapeutics, Inc. 40.29M
CorMedix, Inc. 443.22M
Eloxx Pharmaceuticals, Inc. 16.97M
Cannabis Global, Inc. 6.178M
Breakthrough Chemistry, Inc. 0.4631M

Total Liabilities (Quarterly) Related Metrics